日科化學(300214.SZ)控股股東之一致行動人累計增持295.38萬股
格隆匯4月8日丨日科化學(300214.SZ)公佈,公司於今日收到控股股東濟南魯民投金湖投資合夥企業(有限合夥)之一致行動人魯民投基金管理有限公司(以下簡稱“魯民投基金”)的通知,獲悉魯民投基金通過其管理的基金“魯民投點金一號私募證券投資基金”,自2019年3月19日至2019年5月8日期間,通過深圳證券交易所交易系統合計增持公司股份295.38萬股,佔公司總股本的0.69%。
本次增持前,魯民投基金持有公司股份3111.1251萬股,佔公司總股本的7.31%;本次增持後魯民投基金持有公司股份3406.5051萬股,佔公司總股本的8.00%。一致行動人濟南魯民投金湖投資合夥企業(有限合夥)持有公司股份6206.7859萬股,佔公司總股本的14.58%。魯民投基金及其一致行動人合計持有公司股份9613.2910萬股,佔公司總股本的22.58%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.